- NCT00210821
- Primary Citation Trial has yet to be published
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment347% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberCAPSS-277Data PartnerJohnson & JohnsonCondition StudiedMigraine DisordersMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Clinical Study Report Available